No abstract available
MeSH terms
-
Antipsychotic Agents / adverse effects
-
Antipsychotic Agents / therapeutic use*
-
Aripiprazole
-
Basal Ganglia Diseases / chemically induced
-
Basal Ganglia Diseases / prevention & control
-
Humans
-
Piperazines / adverse effects
-
Piperazines / therapeutic use*
-
Quinolones / adverse effects
-
Quinolones / therapeutic use*
-
Receptors, Dopamine D2 / drug effects*
-
Receptors, Dopamine D2 / physiology
-
Schizophrenia / drug therapy*
-
Schizophrenia / physiopathology
-
Treatment Outcome
Substances
-
Antipsychotic Agents
-
Piperazines
-
Quinolones
-
Receptors, Dopamine D2
-
Aripiprazole